A detailed history of Front Row Advisors LLC transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Front Row Advisors LLC holds 84 shares of IART stock, worth $1,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84
Previous 84 -0.0%
Holding current value
$1,668
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$33.4 - $45.2 $2,805 - $3,796
84 New
84 $2,000
Q1 2023

May 22, 2023

BUY
$52.61 - $60.49 $4,156 - $4,778
79 Added 1580.0%
84 $5,000
Q1 2023

May 15, 2023

SELL
$52.61 - $60.49 $4,156 - $4,778
-79 Reduced 94.05%
5 $8,000
Q4 2017

Feb 01, 2018

BUY
$46.22 - $51.77 $3,882 - $4,348
84
84 $4,000

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.66B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.